Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats

被引:29
|
作者
Wang, Jianping [1 ]
Zhang, Qing [1 ]
Mei, Xiuhua [1 ]
Zhang, Xiuzhen [1 ]
机构
[1] Yantai Yuhuangding Hosp, Yantai 264000, Shandong, Peoples R China
关键词
Anti-apoptosis; metalloproteinases; Hydroxysafflor Yellow A; left cardiac remodeling; left ventricular remodeling; MATRIX-METALLOPROTEINASE INHIBITION; ESSENTIAL-HYPERTENSION; DYSFUNCTION; APOPTOSIS; MORBIDITY; BCL-2; MASS;
D O I
10.3109/13880209.2013.805791
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Context: Hydroxysafflor yellow A (HSYA), the main chemical component of the safflower yellow pigments, is used extensively in traditional Chinese medicine for the treatment of cerebrovascular and cardiovascular diseases. Objective: The present study determined the effects of HSYA on left ventricular hypertrophy after pressure overload and investigated the underlying mechanisms. Materials and methods: Cardiac hypertrophy was induced by the ligation of abdominal aorta in male Wistar rats. The rats were then divided into five groups and treated with captopril (100 mg/kg) or HSYA at different doses (0, 10, 20 and 40 mg/kg). Six weeks after treatment, the weight of left ventricle, LVMI (left ventricular mass index) and pathological changes were measured. MMP-2 (metalloproteinase 2) and MMP-9 (metalloproteinase 9) levels were determined by ELISA. Protein expressions of Bcl-2 and Bax were evaluated by immunohistochemistry. Results: HSYA (20, 40 mg/kg) significantly attenuated the increase of LVMI (ventricular weight/body weight) by 13.04 and 30.43% respectively, when compared with the model group. This was associated with the amelioration of pathological lesion, such as cardiac muscle fibers were smaller and the nuclei of cardiomyocytes were lightly stained in animals treated with HSYA (20, 40 mg/kg). In addition, the administration of HSYA at doses of 20 and 40 mg/kg increased the Bcl-2/Bax ratio (1.17 +/- 0.08 and 1.39 +/- 0.07 versus 0.71 +/- 0.06). In addition, the serum MMP-2 and MMP-9 levels were blocked by the treatment at doses of 20 and 40 mg/kg HSYA (MMP-2, 76.1 +/- 9.2 and 65.6 +/- 6.8 versus 82.9 +/- 6.2, ng/ml; MMP-9, 66.6 +/- 4.8 and 57.5 +/- 5.0 versus 83.5 +/- 6.0, ng/ml). Conclusion: These findings indicated that HSYA has beneficial effects on hypertensive ventricular remodeling, which may involve mechanisms of inhibiting cell apoptosis and suppressing metalloproteinases expression.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 50 条
  • [41] Apocynin Ameliorates Pressure Overload-Induced Cardiac Remodeling by Inhibiting Oxidative Stress and Apoptosis
    Liu, J. -J.
    Lu, Y.
    Ping, N. -N.
    Li, X.
    Lin, Y. -X.
    Li, C. -F.
    PHYSIOLOGICAL RESEARCH, 2017, 66 (05) : 741 - 752
  • [42] Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice
    Ye, Yong
    Gong, Hui
    Wang, Xingxu
    Wu, Jian
    Wang, Shijun
    Yuan, Jie
    Yin, Peipei
    Jiang, Guoliang
    Li, Yang
    Ding, Zhiwen
    Zhang, Weijing
    Zhou, Jingmin
    Ge, Junbo
    Zou, Yunzeng
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 65 (06) : 628 - 639
  • [43] EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats
    Rui SHENG~(2
    3 Suzhou Institute of Chinese Materia Medica
    ActaPharmacologicaSinica, 2007, (02) : 191 - 201
  • [44] EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats
    Rui Sheng
    Zhen-lun Gu
    Mei-lin Xie
    Wen-xuan Zhou
    Ci-yi Guo
    Acta Pharmacologica Sinica, 2007, 28 : 191 - 201
  • [45] Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy
    Zhu, Xuehai
    Fang, Jing
    Gong, Jun
    Guo, Jun-Hong
    Zhao, Guang-Nian
    Ji, Yan-Xiao
    Liu, Hong-Yun
    Wei, Xiang
    Li, Hongliang
    HYPERTENSION, 2016, 67 (05) : 866 - 877
  • [46] EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats
    Sheng, Rui
    Gu, Zhen-lun
    Xie, Mei-lin
    Zhou, Wen-xuan
    Guo, Ci-yi
    ACTA PHARMACOLOGICA SINICA, 2007, 28 (02) : 191 - 201
  • [47] IMPACT OF BLOOD PRESSURE COMPONENTS ON LEFT VENTRICULAR HYPERTROPHY REMODELING
    Kunisek, Juraj
    Kunisek, Leon
    ACTA CLINICA CROATICA, 2018, 57 (04) : 638 - 645
  • [48] A Murine Model of Pressure Overload-Induced Right Ventricular Hypertrophy and Failure by Pulmonary Trunk Banding
    Nielsen-Kudsk, Anders Hammer
    Schwab, Janne
    Axelsen, Julie Sorensen
    Andersen, Asger
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2024, (208):
  • [49] Trimetazidine treatment influence on pressure overload induced ventricular remodeling and heart failure in rats
    Ma, Jiangwei
    Liu, Huajin
    Qiao, Zengyong
    Cheng, Wenbo
    Wang, Hongwei
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2012, 6 (17): : 3948 - 3955
  • [50] Role of Exercise on Alleviating Pressure Overload-Induced Left Ventricular Dysfunction and Remodeling via AMPK-Dependent Autophagy Activation
    Ma, Zhichao
    Qi, Jie
    Gao, Li
    Zhang, Jun
    INTERNATIONAL HEART JOURNAL, 2020, 61 (05) : 1022 - 1033